Threonine Acids Market Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025

Global threonine acids market is expected to grow at a rapid pace over the next seven years. Increase in meat consumption across the globe coupled with rising population in emerging countries is expected to drive the market over the forecast period. Improved efficiency and reduced waste plays an important role in shaping the industry over other conventional amino acids such as lysine, methionine.

Threonine is an essential amino acid and needs to be ingested from external sources. It is a precursor to glysine and it is used as additive to the drug. This helps in improved performance of the particular drug.

Major end-use applications include the pharmaceuticals, dietary supplements and feed industry. Threonine is used as a feed additive for livestock and in multiple nervous system disorder treatment. Poultry dominates the feed additive usage, followed by the swine breeding industry. Growing feed additives demand for livestock is expected to have positive influence on the overall market.

High amino acid feed requirement coupled with rising feed prices is also expected to compliment the overall market growth. Multiple functions in animal feed and large scale economical production capabilities are anticipated to drive the global threonine acids market over the forecast period.

Steadily growing global population and increase in disposable income among consumers in emerging countries such as Brazil, India, China and Russia are presumed to benefit the overall market growth from 2015 to 2022.

Tight raw material supply and stringent regulatory norms are anticipated to retard threonine acids market profitability and growth over the next six years. Alternate protein sources may emerge as a major challenge for the overall market growth.

However, high meat products and feed additives demand promise the requisite opportunities for the threonine acids industry participants. New technologies and product innovations with a focus on reducing livestock production cost present themselves as major opportunities for the market participants. Large multinational companies are setting up R&D centers and production units in Asia Pacific to cater to the growing market demand.

Asia Pacific threonine acids market was the most dominant region in 2013 and accounted for the maximum revenue share. Rising disposable income coupled with increasing protein-rich food demand in emerging economies such as China, Indonesia, Malaysia, Vietnam, Pakistan, Bangladesh and India is expected to fuel the regional market growth.

High feed additives demand and massive meat consumption in North America is also anticipated to drive the overall threonine acids market demand. Brazil is expected to witness significant growth over the next six years. Countries such as Germany, France, UK and Russia promises significant growth over the next seven years. However, economic crisis in Europe may lead to a slightly moderate market growth in the region.

Global threonine acids industry is highly fragmented. Presence of numerous small to medium scale manufacturers in the threonine acids industry results in this trend. Large number of unorganized sector in countries such as China and India holds a significant share in the market.

Entry barriers for new entrants are minimal. Lower switching costs owing to large number of business players makes the consumers stay at a higher position in terms of bargaining. R&D initiatives from major industry participants are expected to create ample opportunities. In May, 2015, Ajinomoto Co. Inc., a threonine acids manufacturer announced that they raised the selling prices by USD 250 per ton to adjust with the rising prices in Europe.

Other threonine acids market participants include Evonik, Archer Daniels Midland Company, Prinova, D&O Pharmachem, Inc., Shanghai Seebio Biotech, Inc., Degussa Corporation, The Graymor Chemical Co., Inc., Viachem Ltd., Foodchem International Corporation, Yore Chemipharm Co., Ltd., Pharmline Inc., Peptides International, Viachem Ltd., Pacific Rainbow International, Inc. and Biomatik Corporation.